NDC 70868-703
Dr Manzanilla PE
Phenylephrine Hydrochloride, Triprolidine Hydrochloride
Dr Manzanilla PE is a Oral Syrup in the Human Otc Drug category. It is labeled and distributed by Key Therapeutics. The primary component is Triprolidine Hydrochloride; Phenylephrine Hydrochloride.
| Product ID | 70868-703_0b1b7736-e381-423a-b0fe-35af2e23a883 |
| NDC | 70868-703 |
| Product Type | Human Otc Drug |
| Proprietary Name | Dr Manzanilla PE |
| Generic Name | Phenylephrine Hydrochloride, Triprolidine Hydrochloride |
| Dosage Form | Syrup |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-08-11 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Key Therapeutics |
| Substance Name | TRIPROLIDINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE |
| Active Ingredient Strength | 3 mg/5mL; mg/5mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |